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LAW ENFORCEMENT AND EXECUTIVE ORDER: DUPLICATION 
IN MISSOURI’S PRESCRIPTION DRUG MONITORING PROGRAM 
ABSTRACT 
Missouri had long been scrutinized as the only state operating without a 
prescription drug monitoring program. These programs are seen as an effective 
way to monitor prescription opioids as opioid-related deaths have risen in the 
past decade. The opioid crisis has gained significant media attention and cast 
scrutiny on pharmaceutical companies, physicians, and state and federal 
governments. This comment explores the history of the opioid crisis and details 
Missouri’s struggle to implement a prescription drug monitoring program 
legislatively. In 2017, former Governor Eric Greitens signed an Executive Order 
directing the Missouri Department of Health and Senior Services to implement 
one of these programs. This program is centered on law enforcement, and as 
written, aims to monitor and collect data that is already available via alternative 
means. For Missouri to successfully combat the opioid crisis, the state needs to 
utilize resources already at its disposal to create an effective means of 
monitoring prescription opioids. At the time of publication, the program had 
been implemented; however, there is no available data currently available to 
determine the effectiveness of the program. 
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I.  INTRODUCTION 
Beginning in 1999, the use of opioids, both legal and illegal, has risen 
drastically; opioid-related deaths have increased significantly over the past 
decade.1 This crisis has quickly become one of the most discussed issues in the 
United States. Media coverage has increased with state and federal legislatures 
shining light on the issue as they struggle to find a solution. In October of 2016, 
President Trump declared the opioid crisis a “public health emergency.”2 At the 
time of his announcement, he had not requested any funds to combat the issue 
but plans on “really tough, really big, really great advertising” as a means to help 
minimize the number of those addicted to opioids in the nation.3 The President 
revisited this issue in his first State of the Union Address in January of 2018,4 
and in March, the White House established a new website “where Americans 
can share their own stories about the dangers of opioid addiction.”5 Many states 
have undertaken differing and even multiple approaches to combat the number 
of opioid-related deaths they see in their state.6  
Missouri, like the nation, has not been immune to the effects of opioids.7 
While opioids, when prescribed and used appropriately, can be effective at 
managing pain, the misuse of these drugs can lead to addiction and death. 
Missouri’s high use of opioids, especially in rural areas, is attributed to fewer 
options for pain management like physical therapy, older populations that are 
prescribed opioids for cancer or end-of-life treatment, and urban areas that have 
greater access to illegal drugs like heroin.8 While Missouri has been aware of 
this growing problem, the legislature has been unsuccessful in passing 
legislation to create a statewide prescription drug monitoring program (PDMP).9 
In July of 2017, Missouri Governor Eric Greitens attempted to tackle the use 
of opioids in Missouri by signing an executive order, directing the Department 
 
 1. Understanding the Epidemic, CTRS. FOR DISEASE CONTROL & PREVENTION (Aug. 30, 
2017), https://www.cdc.gov/drugoverdose/epidemic/index.html. 
 2. Julie Hirschfeld Davis, Trump Declares Opioid Crisis a ‘Health Emergency’ But Requests 
No Funds, N.Y. TIMES (Oct. 26, 2017), https://www.nytimes.com/2017/10/26/us/politics/trump-
opioid-crisis.html. 
 3. Id. 
 4. President Donald J. Trump, State of the Union Address (Jan. 30, 2018). 
 5. The Opioid Crisis, WHITE HOUSE, https://www.whitehouse.gov/opioids/ (last visited Oct. 
13, 2018). 
 6. See Gale Pryor, 6 Ways States are Fighting the Opioid Epidemic, ATHENA INSIGHT (May 
19, 2017), https://www.athenahealth.com/insight/6-ways-states-are-fighting-opioid-epidemic. 
 7. Andy Marso, These are the Most Opioid-Soaked Counties in Kansas and Missouri, KAN. 
CITY STAR (July 30, 2017), http://www.kansascity.com/news/business/health-care/article1643078 
57.html. 
 8. Id. 
 9. Rick Morgan, Running Out of Time: Missouri’s Opioid Epidemic, VOX MAG. (Apr. 6, 
2017), http://www.voxmagazine.com/news/features/running-out-of-time-missouri-s-opioid-epi 
demic/article1b2d4f10-1ad2-11e7-a4e0-7f7f4ba7c6e6.html. 
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of Health and Senior Services (DHSS) to implement a statewide PDMP using a 
three-step process.10 The program went into effect at the end of the 2017 
calendar year, with data already being shared between prescribers and the state 
via a pharmacy benefit management firm.11 The program he proposed is not 
designed to operate as a traditional PDMP, but rather as a surveillance program. 
The data that Governor Greitens’s order collects is already available through 
other means in the state of Missouri. The state currently utilizes a statewide 
health information exchange (HIE) that shares electronic medical records 
(EMRs) with participants across the state, as well as smaller HIEs that operate 
regionally. In Missouri, the Bureau of Narcotics and Dangerous Drugs (BNDD) 
must maintain a registry of practitioners who deal with controlled substances, 
including Schedule II opioids, and there are currently reporting requirements for 
practitioners and pharmacists for controlled substances that are dispensed.  
The Executive Order to implement a PDMP aims to combat the opioid crisis 
by punishing prescribers. However, the data that is collected and turned over to 
law enforcement is already available to law enforcement via multiple means, 
making Missouri’s PDMP an additional and duplicative step in monitoring 
prescription opioids. This comment will explore how and why there was a rise 
in the number of prescription opioids across the nation, discuss PDMPs as a way 
to monitor opioids, navigate Missouri’s struggle with opioid-related deaths and 
lack of legislation to combat those deaths, and examine why Missouri’s PDMP 
is a law enforcement-centered program that is duplicative of other systems that 
are already in place to monitor the amount of prescribed and dispensed opioids 
in the state. Finally, this comment will conclude with an evaluation of Nebraska 
and how the state has dealt with the increase in opioids as a best practice and 
potential model for Missouri, which the state should adopt as an alternative 
practice in monitoring opioids dispensed throughout the state.  
II.  OPIOID CRISIS 
To first understand the impacts that opioids have had across the country, one 
must look to the history of opioids in the United States; prescribing practices 
have changed over time prior to landing in the current landscape where the 
amount of opioid use (and deaths) are called both a “crisis” and “epidemic.”12 
 
 10. Mo. Exec. Order No. 17-18 (July 17, 2017). 
 11. Jack Suntrup & Samantha Liss, Missouri’s Version of Long-Awaited Prescription 
Monitoring Program is Up and Running, ST. LOUIS POST DISPATCH (Dec. 9, 2017), http://www.stl 
today.com/news/local/govt-and-politics/missouri-s-version-of-long-awaited-prescription-monitor 
ing-program-is/article_082eaa5c-a898-5510-9158-557a2bef144c.html. 
 12. See generally Opioid Overdose Crisis, NAT’L INST. ON DRUG ABUSE (Mar. 2018), 
https://www.drugabuse.gov/drugs-abuse/opioids/opioid-overdose-crisis; Opioid Crisis Fast Facts, 
CNN (May 27, 2018), https://www.cnn.com/2017/09/18/health/opioid-crisis-fast-facts/index.html; 
What is the U.S. Opioid Epidemic?, DEP’T OF HEALTH & HUMAN SERVS. (Mar. 6, 2018), 
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Opioid use in the United States did not begin over the past three decades; opioids 
were used recreationally and for pain management in the United States for 
centuries. When morphine was extracted from opium in 1803, it was used to 
treat pain in the Civil War.13 After seeing the addictive effects of opioids, 
scientists worked to develop a less addictive solution that maintained the 
effectiveness in relieving pain of opioids. This led to the development of heroin, 
which was more addictive than the morphine that was previously used.14 
Medical professionals, seeing the addictive effects of both morphine and heroin, 
were concerned with opioid use, which resulted in a decline in medical opioids 
through the twentieth century.15 Research continued to search for alternatives, 
leading to the introduction of Vicodin and Percocet, which were made using 
synthetic opioids.16  
The most credited reason for the increase in prescribing opioids in past 
decades relates back to the state of medicine during the 1990s. During this time, 
physicians were told that they were not adequately treating patients’ pain.17 
Patients were surveyed as they left hospitals after receiving treatment, and while 
their ailment or reason for visit may have been treated, their pain was not.18 In 
addition, there is evidence that untreated pain hampers healing and recovery 
from opiod addiction, which can lead to self-medication and the purchase of 
illegal opioids.19 There then came a greater push for physicians not only to treat 
ailments, diseases, and the like, but also to treat patients’ pain.20 Pain was 
introduced as the “fifth vital sign” to be assessed during treatment, and pain was 
treated as a public health issue.21 In response, pharmaceutical companies began 
to more aggressively market opioids, such as OxyContin.22 Physicians faced 
 
https://www.hhs.gov/opioids/about-the-epidemic/; America’s Opioid Epidemic, CBS NEWS, 
https://www.cbsnews.com/opioid-epidemic/ (last visited Oct. 13, 2018). 
 13. NAT’L ACADS. OF SCIS., ENG’G, & MED., PAIN MANAGEMENT AND THE OPIOID 
EPIDEMIC: BALANCING SOCIETAL AND INDIVIDUAL BENEFITS AND RISKS OF PRESCRIPTION 
OPIOID USE 1–6, 24 (2017). 
 14. Id. 
 15. Id. at 1–7. 
 16. Id. 
 17. See generally Rachel Solnick, Prescription Drug Monitoring Programs: Regulatory 
Burden or an Emergency Physician Function?, ACEP NOW (July 15, 2016), http://www.acepnow. 
com/article/prescription-drug-monitoring-programs-regulatory-burden-emergency-physician-func 
tion/?singlepage=1&theme=print-friendly. 
 18. See generally id. 
 19. Amy Wachholtz et al., Intersection of Chronic Pain Treatment & Opioid Analgesic 
Misuse: Causes, Treatments, & Policy Strategies, SUBSTANCE ABUSE & REHABILITATION, Aug. 
17, 2011, at 146, 157. 
 20. Solnick, supra note 17.  
 21. Id.; Daniel S. Goldberg & Summer J. McGee, Pain as a Global Public Health Priority, 
BMC PUB. HEALTH, Oct. 6, 2011, at 3. 
 22. Solnick, supra note 17; Wachholtz et al., supra note 19, at 146; see also NAT’L ACADS. 
OF SCIS., ENG’G, MED., supra note 13 at 1–8. 
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backlash when they were told they were not adequately treating pain; physicians 
are now facing backlash for prescribing too many opioids in the attempt to treat 
pain. Now, physicians face finger pointing and blame from families affected by 
opioids, legislatures, and even the media, not to mention punishment from law 
enforcement and licensing boards.23 
The increase in the amount of prescription opioids, such as oxycodone, 
hydrocodone, and methadone, has risen since 1999, and opioid-related deaths 
are associated with that increase since that time.24 The Centers for Disease 
Control and Prevention (CDC) report data on four categories of opioids: natural, 
synthetic, methadone, and heroin.25 The CDC estimates that 115 Americans die 
from an opioid overdose every day.26 While the CDC is reporting increases in 
prescription opioids and deaths related to overdoses, they admit that the data 
they report may not be complete.27 This may be attributed not only to an increase 
in prescription drugs, but also an increase in the illegal use of heroin and 
fentanyl.28 The CDC is not the only agency reporting an increase in opioid-
related deaths; law enforcement is also reporting greater numbers of synthetic 
opioids on the market.29 Even in the early 2000s when authorities were seeing 
tampering and illegal selling of prescriptions, pharmaceutical sales of opioids 
continued to increase.30 In addition to the increase in deaths, “adverse health 
consequences resulting from prescription drug misuse—including overdose 
events, emergency department (“ED”) visits, and inpatient admissions—have 
escalated dramatically.”31 The rise in opioid-related deaths has increased more 
quickly in the United States than in other countries.32  
While there has been an increase in opioid overdoses, the majority of 
patients “prescribed opioids do not misuse them.”33 A common use of opioids is 
 
 23. Solnick, supra note 17; Marcia Frellick, Physicians Get Too Much Blame for Opioid 
Crisis, Some Say, MEDSCAPE (June 24, 2018), https://www.medscape.com/viewarticle/885760# 
vp_3; see also, Sarah Schulte, Wheaton Family Sues Hospital Over Grandmother’s Opioid 
Overdoes Death, ABC7CHICAGO (May 11, 2018), http://abc7chicago.com/health/wheaton-family-
sues-hospital-over-grandmothers-opioid-overdose-death/3461909/. 
 24. Understanding the Epidemic, supra note 1. 
 25. Opioid Data Analysis, CTRS. FOR DISEASE CONTROL & PREVENTION (Feb. 9, 2017), 
https://www.cdc.gov/drugoverdose/data/analysis.html. 
 26. Understanding the Epidemic, supra note 1. 
 27. Pat Anson, CDC Admits Rx Opioid Deaths ‘Significantly Inflated’, PAIN NEWS NETWORK 
(Mar. 21, 2018), https://www.painnewsnetwork.org/stories/2018/3/21/cdc-admits-rx-opioid-
deaths-significantly-inflated. 
 28. Opioid Data Analysis, supra note 25.  
 29. Id. 
 30. NAT’L ACADS. OF SCIS., ENG’G, AND MED., supra note 13, at 1–8. 
 31. Rebecca L. Haffajee, Preventing Opioid Misuse with Prescription Drug Monitoring 
Programs: A Framework for Evaluating the Success of State Public Health Laws, 67 HASTINGS 
L.J. 1621, 1630 (2016). 
 32. NAT’L ACADS. OF SCIS., ENG’G, & MED., supra note 13, at ix. 
 33. Id. at S-2. 
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to manage chronic pain in patients suffering from cancer and end-of-life 
treatment. Those who are being treated for acute pain with opioids, however, 
may experience the positive and euphoric feelings of the drugs, leading to the 
addiction that patients may face.34 The physicians prescribing opioids are not 
the only cause to the increase of opioids; “while increased opioid prescribing for 
chronic pain has been a vector of the opioid epidemic, researchers agree that 
such structural factors as lack of economic opportunity, poor working 
conditions, and eroded social capital in depressed communities, accompanied by 
hopelessness and despair, are root causes of the misuse of opioids . . . .”35 
Physicians should not have to shoulder all the blame for this issue; there are 
many factors that have led to the increase of opioids, and the focus should be on 
how to prevent opioid abuse and overdose.  
A. State Strategies to Address Opioid Misuse 
States have not sat idly by waiting for the opioid crisis to solve itself; 
numerous strategies have been presented to states as suggestions on how to limit 
opioid-related deaths. The Commission on Combatting Drug Addiction and 
Opioid Crisis released a draft of a report that outlines suggestions for states to 
follow in working to limit the number of opioid-related deaths.36 Some of the 
suggestions for prescribers include Medication Assistance Treatment 
programs37 and PDMPs with interstate sharing systems allowing prescribers to 
have access to patient prescription data.38 Other suggested approaches include: 
setting prescribing limits and guidelines for physicians, which would limit the 
dose and amounts of opioids; expanding access to treatment to those suffering 
addiction, including providing sufficient insurance coverage for inpatient 
treatment facilities; working to minimize the long wait for those seeking 
treatment in those facilities; and expanding access to the drug Naloxone, which 
“blocks the effects of opioids to reverse overdoses within minutes.”39 
Continuing Medical Education for prescribers is a commonly recommended 
strategy that relates directly to the amount of prescription opioids on the market. 
Fully implementing this strategy will necessitate “a fundamental shift in the 
 
 34. Id. at 3–29. 
 35. Id. at 1–19. 
 36. COMM’N ON COMBATING DRUG ADDICTION & THE OPIOID CRISIS, INTERIM REPORT 2 
(2017), https://www.whitehouse.gov/sites/whitehouse.gov/files/ondcp/commission-interim-re 
port.pdf. 
 37. See Medication-Assisted Treatment, SUBSTANCE ABUSE & MENTAL HEALTH SERVS. 
ADMIN. (last updated Feb. 7, 2018), https://www.samhsa.gov/medication-assisted-treatment 
(explaining this approach implements “the use of FDA-approved medications, in combination with 
counseling and behavioral therapies, to provide a ‘whole-patient’ approach to the treatment of 
substance use disorders.”). 
 38. COMM’N ON COMBATING DRUG ADDICTION & THE OPIOID CRISIS, supra note 36, at 7. 
 39. Pryor, supra note 6. 
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nation’s approach to mandating pain-related education for all health 
professionals who provide care to individuals with pain. Prescribing guidelines 
may be able to improve provider prescribing behavior, but may be most effective 
when accompanied by education and other measures to facilitate 
implementation.”40 The Food and Drug Administration (FDA) recommends 
employing mitigation strategies in an attempt to be proactive in combatting 
opioid use as well as creating a greater push for abuse-deterrent opioids, for 
example, pills that are more difficult to crush and be used recreationally.41  
Thirteen states have implemented limits on prescription opioid amounts in 
order to limit opioid use.42 Working to prevent opioid addiction from the start is 
another way to limit the number of prescribed opioids, as well as identifying and 
treating early cases of addiction and effectively treating those who are currently 
addicted.43 Some states require a physical examination prior to prescribing 
opioids, or at least an evaluation of the patient “that is deemed ‘appropriate’… 
instead of or in addition to the physical examination laws.”44 Opioid misuse 
strategies can be categorized into three stages: primary, secondary, and tertiary 
prevention.45 These intervention strategies address opioid use from initiation to 
prescription (i.e. prescriber education, manufacturer regulation), to screening for 
addiction (including urine testing and PDMPs), and finally to addressing 
addiction through rehabilitation.46 
B. PDMPs 
Of the many suggestions and strategies, all states (including Missouri as of 
2017) have chosen to implement PDMPs.47 PDMPs can be used not only to limit 
the number and dosage of opioids a patient receives, but they also help a 
prescriber or pharmacist identify any potential conflicts a patient may have with 
 
 40. NAT’L ACADS. OF SCIS., ENG’G, & MED., supra note 13, at S-10. 
 41. Dani Kass, 3 Takeaways from the FDA Head’s New Opioid Rx Standards, LEXIS LAW360 
1–2 (July 12, 2017), https://advance.lexis.com/document/?pdmfid=1000516&crid=8901a68c-b0 
9a-4612-b403-1c07b1d5a28a&pddocfullpath=%2Fshared%2Fdocument%2Flegalnews%2Furn% 
3AcontentItem%3A5P0S-N6B1-F22N-X290-00000-00&pddocid=urn%3AcontentItem%3A5P0 
S-N6B1-F22N-X290-00000-00&pdcontentcomponentid=122080&pdteaserkey=sr0&ecomp=kyf 
fk&earg=sr0&prid=0997b46d-12ac-4d45-bb68-45eb2aef646e. 
 42. Pryor, supra note 6. 
 43. Haffajee, supra note 31, at 1631–32. 
 44. Prescription Drug Physical Examination Requirements, CTRS. FOR DISEASE CONTROL & 
PREVENTION 1, 3 (Jan. 29, 2015), https://www.cdc.gov/phlp/docs/pdpe-requirements.pdf. 
 45. Haffajee, supra note 31, at 1633–34. 
 46. Id. 
 47. See id. at 1635; see also Jason Hancock & Andy Marso, Gov. Eric Greitens Orders 
Prescription Drug Monitoring Program for Missouri, KAN. CITY STAR (July 17, 2017), 
http://www.kansascity.com/news/local/news-columns-blogs/the-buzz/article161759233.html. 
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existing medications.48 PDMPs are an achievable means of allowing prescribers 
to track prescription information for a patient, even though state laws differ in 
what information can be viewed and tracked.49 Goals of a PDMP include: 
improving patient treatment decisions; influencing prescribing practices; 
assisting in the identification of “doctor shoppers;” and serving as a tool for law 
enforcement.50 When a physician utilizes a PDMP, she can see if the patient has 
on-going opioid prescriptions, if the patient is receiving the same prescription 
from multiple doctors,51 and even the dose, supply, and prescriber of other 
prescriptions,52 allowing the physician to determine if the patient is an addict or 
abuser of prescription opioids. Studies suggest the mandatory use of PDMPs is 
best practice; unsurprisingly, PDMPs have been shown to be most effective in 
states that mandate their use.53 When use is not mandated, little more than half 
of physicians regularly utilize their state’s PDMP,54 undercutting the value a 
PDMP could have to prescribers and their state’s efforts to more closely monitor 
and limit the number of prescription opioids dispensed. To more effectively 
utilize PDMPs: 
The U.S. Department of Health and Human Services, in concert with state 
organizations that administer prescription drug monitoring programs, should 
conduct or sponsor research on how data from these programs can best be 
leveraged for patient safety (e.g., data on drug–drug interactions), for 
surveillance of policy and other interventions focused on controlled substances 
(e.g., data on trends in opioid prescribing, effects of prescriber guidelines), for 
health service planning (e.g., data on discrepancies in dispensing of medications 
for treatment of opioid use disorder), and for use in clinical care (i.e., in clinical 
decision making and patient–provider communication).55 
The data found in a PDMP can have beneficial effects beyond merely tracking 
prescription history.  
There are generally two goals when implementing a PDMP: public health 
and law enforcement. PDMPs that utilize public health as their primary goal 
 
 48. Austin Frakt, A Helpful Tool to Combat the Opioid Crisis, N.Y.TIMES (Sept. 11, 2017), 
https://www.nytimes.com/2017/09/11/upshot/a-helpful-tool-to-combat-the-opioid-crisis.html. 
 49. NAT’L ACADS. OF SCIS., ENG’G, & MED., supra note 13, at S-10. 
 50. Lainie Rutkow et al., Prescription Drug Monitoring Program Design and Function: A 
Qualitative Analysis, 180 DRUG & ALCOHOL DEPENDENCE 395, 397 (2017) (explainging while a 
PDMP can be used as a tool for law enforcement, “providing data to health care providers was, in 
general, the primary purpose of the PDMP.”). 
 51. Frakt, supra note 48. 
 52. Haffajee, supra note 31, at 1634. 
 53. See, e.g., Frakt, supra note 48; Janet Weiner et al., Prescription Drug Monitoring 
Programs: Evolution & Evidence, LEONARD DAVIS INST. OF HEALTH ECON. 1, 6 (2017), 
https://ldi.upenn.edu/sites/default/files/pdf/LDI%20CHERISH%20Brief_Prescription%20Drug%
20Monitoring%20Programs.pdf. 
 54. Weiner et al., supra note 53, at 1. 
 55. NAT’L ACADS. OF SCIS., ENG’G, & MED., supra note 13, at S-11. 
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have a greater focus on lowering the amount of opioid-related deaths and access 
to treatment and education to those suffering opioid addiction.56 Public health 
should not be only on the minds of those initiating a PDMP; the FDA should 
also incorporate public health issues when making “regulatory decisions 
regarding opioids.”57 In the CDC’s suggested strategies for states to fight the 
abuse of opioids, the strategies suggested focus on evaluating programs that are 
currently in place, not punishing prescribers or patients with the involvement of 
law enforcement.58 Because the amount of opioid use is considered a public 
health concern, PDMPs should keep public health goals at the forefront of their 
implementation to address a more holistic approach to confronting opioid abuse.  
PDMPs with law enforcement as their primary goal focus on the prescription 
abuse side of the opioid crisis.59 They do this by working to punish the 
prescribers and dispensers of opioids as well as the patients who abuse them.60 
This focus on law enforcement creates tension among the medical community, 
leaving physicians feeling like there is someone “looking over their 
shoulders.”61 Physicians, working in fields that prescribe a higher than average 
amount of opioids, such as end-of-life and cancer, see law enforcement’s hand 
in their practice as a “nuisance.”62 Law enforcement PDMPs look for instances 
of overprescribing, or deviating from the standard of care, but this term does not 
fully recognize all situations in which a patient may misuse a prescription; 
opioid-seeking patients may be turning around and illegally selling their 
medication.63 In a state that does not mandate the use of the PDMP, physicians 
may choose not to utilize this tool for fear of retribution by law enforcement. 
Fear of punishment may deter some physicians, which may mean less 
prescription opioids, but this refusal may encourage patients to obtain opioids 
illegally. Patients who have legitimate need for opioids but are denied by 
physicians who fear law enforcement may turn to other illegal means of pain 
 
 56. M. Mofizul Islam & Ian S. McRae, Commentary, An Inevitable Wave of Prescription Drug 
Monitoring Programs in the Context of Prescription Opioids: Pros, Cons & Tensions, BMC 
PHARMACOLOGY & TOXICOLOGY 1 (2014). 
 57. NAT’L ACADS. OF SCIS., ENG’G, & MED., supra note 13, at 6–26. 
 58. Promising State Strategies, CTRS. FOR DISEASE CONTROL & PREVENTION 
(Aug. 30, 2017), https://www.cdc.gov/drugoverdose/policy/index.html; Islam & McRae, supra 
note 56, at 3. 
 59. Islam & McRae, supra note 56, at 3. 
 60. Id. at 5. 
 61. Carol M. Ostrom, New Prescription Monitoring Draws Complaints, SEATTLE TIMES (Jan. 
3, 2012), http://www.seattletimes.com/seattle-news/new-prescription-monitoring-draws-com 
plaints/. 
 62. Islam & McRae, supra note 56, at 3. 
 63. Kelly K. Dineen & James M. DuBois, Between a Rock and a Hard Place: Can Physicians 
Prescribe Opioids to Treat Pain Adequately While Avoiding Legal Sanction?, 42 AM. J. L. & MED. 
7, 13 (2016). 
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management.64 The majority of people who are abusing opioids are getting them 
illegally.65  
While most PDMPs allow the authorities to gain access to information 
stored on a PDMP,66 state law varies in the scope of the obtainable evidence,67 
and even though law enforcement can obtain evidence from a PDMP, this does 
not mean that the goal of the PDMP is law enforcement. The two most common 
means by which an authorized recipient may receive data from PDMP are: (1) 
“probable cause, search warrant, subpoena, or other judicial process;” and (2) 
“pursuant to an active investigation or as part of official duties.”68 State medical 
licensing boards still have the right to punish physicians whose prescribing 
practices fall below the standard of care, without any interference or 
investigation conducted by law enforcement.69 This should be an efficient check 
on prescribing practices without the involvement of law enforcement. 
With these dual goals, “states must balance the various means used to 
achieve these various purposes against the patients’ expectations of privacy” as 
well as “help states regulate controlled substances and prevent abuse of these 
substances by providing prescribers, dispensers, and law enforcement with the 
information necessary to identify individuals that may be diverting prescription 
drugs from legitimate channels to sell or use illicitly.”70 One of the criticisms of 
PDMPs is the fear that the information shared on these systems will constitute a 
breach of privacy for the patient by allowing a physician to gain access to that 
patient’s prescribing history, even when treating the patient only once. However, 
PDMPs that focus on law enforcement justify their use by balancing the need 
for patient privacy with the need for law enforcement to regulate opioid use.71 
Different states have different requirements for law enforcement to gain access 
to the data. For example, Oregon requires “a search warrant or showing of 
probable cause,” while Pennsylvania requires “approval from the attorney 
general” for access.72 Additionally, “Maine, Nebraska, and Vermont are the only 
states currently that do not have a specific provision in their prescription 
monitoring program laws for access by law enforcement or judicial authorities. 
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However, Nebraska is the only state that specifically prohibits access by law 
enforcement.”73 
PDMPs that allow law enforcement to seek medical information in order to 
punish physicians and abusers must then be tasked with making medical 
decisions, including: “(1) the point at which a medical purpose becomes 
illegitimate; (2) the boundaries of usual practice; and (3) the extent to which 
crossing those boundaries warrants criminal liability.”74 Properly trained law 
enforcement would still lack the capabilities to make medical determinations 
during the course of treatment for a patient. This would mean that law 
enforcement would have the ability to say a patient does not need a certain 
number of pills or a certain dosage to treat the many ailments for which opioids 
are prescribed. When functioning in this way, the PDMP is essentially a tool that 
law enforcement uses to punish, not one that is used to address the underlying 
issues of addiction.75 
C. Missouri’s Struggle with Opioids 
Missouri has not been immune to the opioid crisis, seeing the number of 
deaths rise due to opioid abuse and overdose. In 2016, over 900 Missourians 
died from overdosing on opioids.76 According to the Missouri DHSS, of those 
deaths, approximately 500 were from non-heroin opioids, while the remaining 
were attributed to heroin.77 Rural areas in Missouri are some of the hardest hit, 
with Howell County ranked thirtieth in opioid usage nationally.78 The addictive 
effects of opioids have been widely reported, with opioids generating feelings 
of euphoria and painlessness.79 The chance of addiction of prescription opioids 
is common; “about 35 percent of people prescribed a month’s supply of 
painkillers become hooked for at least a year.”80 Patients who are properly 
prescribed opioids may become addicted, but when patients are cut off from 
legal, prescription opioids, many turn to illegal opioids like heroin and black 
market fentanyl to continue to experience the euphoric effects of opioids and 
prevent withdrawals.81 
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For years, Missouri had no clear direction on how to handle the increasing 
number of patients who abuse their legal opioid prescription or those abusing 
illegal opiates. Missouri Attorney General Josh Hawley attempted action by 
suing pharmaceutical companies claiming their “fraud and deception” led to the 
opioid crisis in Missouri, and Hawley is seeking damages and civil penalties for 
the alleged misrepresentation of the addictive effects of opioids.82 Missouri joins 
other states in these actions, with Mississippi being the first state to bring suit in 
2015.83 While suing pharmaceutical companies for their role in the boom in 
prescription opioids may address the larger social issue of why opioid use 
became so popular, Missouri remained the only state without a PDMP for years. 
State legislature struggled to pass legislation implementing and funding a PDMP 
for years.84 In 2012, legislation to create a PDMP reached the Senate floor but 
was filibustered by Senator Schaaf, a physician, citing patient privacy 
concerns.85 Senator Schaaf and a small number of other senators have effectively 
prevented a PDMP bill from reaching the senate floor.86 Schaaf has admitted 
willingness to implement a PDMP legislatively but has conditioned his support; 
the bill would need to require physician participation and hold them liable for 
overdoses if the system is not appropriately used.87 Senator Rehder, author of 
the bill, agreed to consider his amendments.88 
When it appeared that Missouri could not successfully pass legislation to 
implement one of the most common suggestions for combatting the opioid crisis 
(and one which every other state implemented in some way), St. Louis County 
in Missouri took action. In the spring of 2017, St. Louis County instituted a 
PDMP that would operate first in the county but would eventually be opened to 
counties across the state.89 The St. Louis County PDMP monitors the dispensing 
of Schedule II-IV controlled substances and requires pharmacies to report the 
prescriptions within those categories.90 The PDMP also requires pharmacies to 
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report controlled prescriptions to their county public health department.91 While 
this began as a county program (as opposed to a statewide PDMP), St. Louis 
County offered any county in Missouri to join their efforts and become a part of 
this program; since its initial implementation, other counties, which account for 
fifty-eight percent of Missouri’s population, have joined.92 The St. Louis County 
PDMP was up and running in April of 2017. The goals of this program are based 
in public health:  
(1) Improve controlled substance prescribing by providing critical information 
regarding a patient’s controlled substance prescription history, (2) inform 
clinical practice by identifying patients at high-risk who would benefit from 
early interventions, and (3) reduce the number of people who misuse, abuse, or 
overdose while making sure patients have access to safe, effective treatment.93 
III.  LAW ENFORCEMENT AND EXECUTIVE ORDER 
Continued media coverage, criticism of Missouri for being the only state 
operating without a statewide PDMP, the failed attempts to once again to pass 
legislation to implement such a program, and the scrutiny of Missouri’s lack of 
action led Governor Greitens to address the continued rise of opioid-related 
deaths. On July 17, 2017, Governor Eric Greitens announced Executive Order 
17-18, which directed the Missouri DHSS to develop and implement a PDMP.94 
This order laid out three phases for this process. The first phase was to enter into 
a contract with pharmacy benefit management organizations to analyze the 
dispensing data.95 Phase Two requires dispensers statewide to submit the data to 
DHSS, which will then determine if there is a need for investigation. If so, they 
will work with law enforcement and licensing boards.96 The final phase is to 
work with private companies and government entities to purchase technology to 
monitor data.97 After Greitens announced the PDMP in July, Greitens’s goal was 
to get the program implemented and running before the opioid crisis in Missouri 
worsened.98 
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While proponents of a statewide PDMP praised the Governor for taking 
action to help end opioid-related deaths in Missouri, those with more cynicism 
criticized Greitens as merely attempting to appease constituents and his donors. 
The announcement of the Executive Order was made at Express Scripts’ office 
in St. Louis, indicating that Express Scripts was expected to receive the bid to 
begin Phase One and help implement the monitoring program, which they later 
did.99 Another criticism on the proposal was that it “focuse[d] on the prescribers 
and distributors of medications, such as doctors and pharmacists, who are 
already regulated by the state.”100 While the Missouri House Minority Leader 
Gail Beatty called the original announcement a “publicity stunt,” the status of 
the PDMP for Missouri was stalled for months before becoming operational in 
November 2017.101 
Another cause for concern among critics was the order’s break from 
traditional PDMPs. According to the Executive Order, prescribers do not have 
access to a patient’s prescription information, which prevents them from making 
medical decisions in the moment based on a patient’s past prescription 
history.102 Without that information, a physician who writes a prescription for 
someone who may have another active opioid prescription may be punished 
simply because they were unable to access that information using a PDMP. The 
initial belief was that the program proposed by Governor Greitens would 
actually be weaker than the PDMP St. Louis County put in place months 
earlier.103  
The language from the Executive Order makes it clear that the goal of 
Missouri’s PDMP is law enforcement as opposed to public health. Physicians 
and prescribers do not have access to the prescription history of a particular 
patient under this order,104 and there is no mention in the Executive Order about 
helping those addicted to opioids.105 While there has long been a national 
microscope on physicians’ prescribing practice of opioids, the Executive Order 
in Missouri seems to up the ante. Fear of criminal prosecution may lead 
physicians to avoid prescribing opioids at all, even in cases of legitimate need.106 
The Executive Order directs the data to be sent to DHSS or a designee to analyze 
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and determine if there is an issue in prescribing history; in order to determine if 
there was actually a violation, the order calls for an investigation.107 However, 
if the data is going to DHSS and law enforcement, that information may not fully 
actualize the situation that took place before the clinician. Data only offers so 
much information, and as will be discussed later, DHSS already has access to 
data relating to practitioners who dispense opioids. As a law enforcement order 
that prevents physicians from access to the data, this progrm will not work to 
fight the crisis it was put in place to solve.  
The Executive Order is ambiguous and vague on what would trigger an 
investigation into prescribing and dispensing practices. PDMPs in other states 
(and St. Louis County) do not include reports for opioids that are prescribed to 
patients suffering from cancer or receiving end-of-life treatment.108 Counties 
that feature older residents suffering from chronic pain may trigger higher 
reporting rates than a county with younger residents. Certain physicians’ 
practice areas may lend themselves to higher opioid prescribing rates than those 
practicing in other areas, such as pain management, surgery, and rehabilitation, 
as opposed to those practicing in pediatrics, dermatology, and pathology.109 The 
Executive Order is not clear what actions will be taken if dispenser data is not 
reported. 
IV.  DUPLICATION AND EXECUTIVE ORDER 
While the Executive Order that Governor Greitens signed in July of 2017 
was finally operational in November of 2017, the order as written remains 
problematic. If we take this order as written, the focus of the order is to punish 
physicians without a focus on utilizing the goals of public health to combat the 
opioid crisis. The information the PDMP seeks is available to law enforcement 
via other methods. This PDMP is not the most efficient means to combat the 
crisis and create a streamlined patient-care system. 
The BNDD in the DHSS for Missouri requires all practitioners maintain 
strict record keeping regarding controlled substances. The guidelines they have 
for prescribers include specific criteria that must be met when dispensing 
controlled substances, including: (1) “[t]he prescriber must be properly 
registered;” (2) “[t]he patient must desire treatment for a legitimate illness or 
condition;” (3) “[a] practitioner must establish a legitimate need through 
assessment, utilizing pertinent technical diagnostic modalities [and] [t]here must 
be a legitimate practitioner/patient relationship;” and (4) “[t]here must be 
reasonable correlations between the drugs prescribed and the patient’s legitimate 
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needs.”110 Before the practitioner writes a prescription, the controlled substances 
have been “tracked from the day they are made until they are dispensed to a 
patient.”111 When a physician determines there is need for prescription opioids, 
they must keep a log of “all controlled substances received, administered, 
dispensed, or otherwise disposed of” as well as a separate record of controlled 
substances documented in the patient’s chart, including the strength, quantities, 
and refills.112 Those “charts are open for inspection and copying” by BNDD and 
must be made available within three days if requested.113 Practitioners are to 
have the ability to review the record of controlled substances to determine which 
patients are receiving which drugs and how often.114  
Pharmacists in Missouri are also guided by strict rules when filling 
prescriptions for controlled substances. Any time a controlled substance moves 
from one person to another, there must be documentation demonstrating the 
changing of hands, and all records regarding controlled substances must be kept 
for at least two years per state and federal law.115 These records must be “readily 
retrievable” and turned over to BNDD for “inspection and copying” as 
necessary.116 A pharmacy is required to take inventory of controlled substances 
received into the facility and to keep a receipt of the drugs stocked, as well as 
maintain a record of all controlled substances that are filled.117 Information that 
is required when dispensing opioids includes: date of dispense, patient name, 
patient address, drug name, strength, dosage form, and quantity.118 Employees 
of pharmacies are also warned to be aware of “professional patients:” those who 
“patronize 3 or more pharmacies routinely.”119 
While prescribers and pharmacists have to keep stringent records regarding 
the dispensing of controlled substances (including opioids), the BNDD has also 
historically worked with DHSS to ensure controlled substances are being 
properly handled and dispensed. The DHSS “works with law enforcement and 
other agencies to minimize the abuse of controlled substances in the state.”120 
Of the activities in which BNDD participates, one mirrors the previously 
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mentioned behavior that practitioners and pharmacists must undertake: DHSS 
must “maintain[] a registry, as required by state law, of the individuals and firms 
who prescribe, dispense or otherwise conduct activities which involve controlled 
substances.”121 Other activities include: conducting inspections of records held 
by those who dispense opioids; following up on complaints filed about potential 
mishandling of controlled substances; completing audits of those who handle 
opioids; and working “to correct or prevent unlawful practices, when detected, 
through education, or … administrative action against the registration of the 
firms or individuals involved.”122 Working with the primary goal of law 
enforcement, the information that BNDD requests is to be de-identified of 
individual patient information. When requesting information to investigate 
whether controlled substances are being misused, the specific information that 
they seek includes the prescriber, pharmacy, drug name, strength and quantity, 
and date the drug was dispensed.123 
The majority of Missouri also participates in a statewide HIE. Missouri 
Health Connection (MHC) is a system for participants across the state of 
Missouri to share EMRs. Currently, MHC has approximately 1,930 health 
systems and hospitals participating across the state.124 The sharing of EMRs 
allows a physician treating a patient visiting St. Louis to view the patient’s 
medical history and records from the patient’s primary care provider in 
Springfield. The sharing of this information can be vital, especially in 
determining which, if any, prescriptions the physician should write. While the 
purpose of the MHC is to create a system for efficient information sharing and 
better patient outcomes, the information from this system is shared among 
providers.125  
While by law practitioners and pharmacists must keep records of controlled 
substances that are prescribed and dispensed, MHC’s President Angie Bass 
believes that for law enforcement to be involved effectively, “data in the right 
place is key.”126 MHC has implemented tools in order to help streamline the 
process of checking patient information; when a patient with an EMR in the 
system has a recent prescription for opioids, the current treating physician will 
be alerted within the system.127 The purpose of these alerts is to achieve “better 
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care coordination and clinical decision support.”128 Alerts within the system 
would be generated by prescription history and are meant to help the current 
physician from prescribing a duplicate prescription or a prescription that might 
react negatively with a different prescription of record. MHC plans to add more 
tools in 2018 to help those with access to EMRs become even more efficient in 
treating patients and identifying potential drug seekers.129 The MHC HIE is 
similar to a PDMP because providers can see the prescription history of the 
patient, but this information is not turned over to law enforcement without a 
subpoena or as required by law. Even though this is not a traditional PDMP, it 
has the capability of operating like one if MHC has mandatory statewide 
participation; if implemented in this way, the HIE would not be a law 
enforcement-centered PDMP like the one established by Executive Order in 
Missouri. 
Clearly, there are already guidelines in place for physicians and pharmacists 
to follow regarding the prescription and dispensing of controlled substances, 
including opioids. These guidelines are meant to track potentially dangerous 
drugs that have high chances of misuse and addiction. The BNDD, under the 
Missouri DHSS, also works with these entities to ensure that each and every pill 
is accounted for, as well as investigate and audit diversions, or losses, of 
controlled substances.130 The DHSS maintains their own records of those who 
handle or dispense controlled substances but also can request information 
regarding a controlled substance from both prescribers and pharmacists if there 
is an irregularity or sign of potential abuse, either through theft, loss, or 
overprescribing. MHC works to ensure that all EMRs contain necessary and vital 
information to help physicians to make the appropriate choice when prescribing.  
With all this information currently available, what value will Missouri’s new 
PDMP add? While the Executive Order may attempt to streamline data on opioid 
prescriptions, that information is already available. Contracting with a pharmacy 
benefit management organization to analyze the data and then requiring 
dispensers to submit that data to DHSS to determine if there is a need for 
investigation is repetitive of the role that BNDD (working within DHSS) already 
plays in investigations and audits of facilities with controlled substances. While 
Phase Three of the Executive Order, to purchase technology to monitor data, 
could help the entire state, MHC, operating across the state, allows physicians 
to monitor health information for a patient in front of them. While this is a local, 
specific form of monitoring, it is keeping the judgment in the hands of the 
medical professionals as opposed to law enforcement.  
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A. Nebraska as a Model for Missouri 
For Missouri to have the opportunity to truly be successful in minimizing 
opioid-related deaths and cutting down on overprescribing and abusers, the state 
legislature should look to the state of Nebraska and its PDMP as a possible 
model. Nebraska, which was the first state to mandate use of its PDMP, has 
created a partnership that combines its HIE with the PDMP, allowing the two to 
exist together.131 Nebraskans believe that this combination allows the state “to 
close the loop with all prescriptions.”132 Called the NeHII, the purpose is to “aid 
providers in making treatment decisions with a more robust medical history of 
their patient thus aiding and improving the quality and safety of patient care.”133 
The system utilizes a program called DrFirst Medication History that allows 
prescribers, for “purposes of preventing adverse drug events and prescription 
drug monitoring,” to submit a request to “serve up queried medication history to 
the requestor.”134 DrFirst then takes the prescription data generated during the 
visit and submits that information to the PDMP, which will allow pharmacists 
and other dispensers to access that information at the time of treatment.135  
The transmission of electronic data allows the pharmacists to have access 
not only to current prescriptions waiting to be filled, but also to the prescription 
history, which may help identify patients who are abusing the system and 
seeking opioids with the purpose of abusing them.136 This system enables health 
care providers to “monitor the care and treatment” of the patients they are 
treating and confirm that the prescriptions “are used for medically appropriate 
purposes.”137 Proponents recognize that this system has the potential to help curb 
the state’s opioid-related problems in a real and meaningful way by allowing 
physicians and pharmacists to have access to the information.138  
The program not only allows access to patient information in the course of 
treatment, but also alerts practitioners when “patients access several dispensed 
opioid prescriptions and indicate instances in which overlapping prescriptions 
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of opioid medication are being dispensed to the same patient.”139 When 
identifying some of these markers that indicate abuse, physicians and 
pharmacists can work to intervene with the patient by reducing the dose amount 
or substituting a different treatment plan.140 In this way, it is clear that the focus 
of the combined HIE and PDMP is to address the public health concerns related 
to opioid abuse, not merely punish abusers and prescribers. While this new 
program was seen as an added layer in an already complicated industry, there 
was little resistance to the program, and now Nebraska is experiencing a “100 
percent compliance rate for prescription reporting.”141 By combining the PDMP 
with the HIE, Nebraska has created a public health-centered program working 
to identify and address issues prior to administering opioids.  
If Missouri still feels, either from political pressure or public relations, that 
they need its PDMP to combat the use of opioids in the state, then Missouri 
should adopt a model similar to Nebraska’s by integrating the PDMP into the 
HIE system already in place. PDMPs can be an effective tool in identifying and 
addressing those who are abusing opioids. For the PDMP to be most effective, 
it must be centered on addressing the public health issue of opioid addiction as 
opposed to focusing on punishment. Nebraska has incorporated its PDMP with 
a focus on public health with its EMR system. By doing so, they have closed the 
gap of duplicate information, allowing physicians and pharmacists to see 
prescription history of a patient to determine not only if they are merely an 
opioid seeker, but also offer efficient or alternative treatment. If this model is 
adopted by Missouri, this could allow physicians to deliver patient-centered care 
and to make the best decisions about a patient’s course of treatment in the 
moment based on the information found on the HIE. Both pharmacists and 
physicians would still be required to track the number of controlled substances 
that are dispensed and remain subject to inspection by the BNDD allowing for a 
continued check by law enforcement on opioids.  
V.  CONCLUSION 
The United States has been struggling to address the growing number of 
opioid-related deaths and overdoses for the past two decades. Every state has 
responded by implementing a PDMP in order to track opioid prescriptions, with 
Missouri joining the other forty-nine in 2017. These programs tend to be 
designed with one of two goals: public health and law enforcement. In order to 
most effectively end the cycle of addiction to opioids, these programs need a 
public health-centered approach to not only prevent abusers from obtaining 
multiple prescriptions for opioids, but to also offer intervention strategies to help 
those who are addicted.  
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St. Louis County, Missouri attempted to address the issues occurring in the 
community by starting a county-operated PDMP. Once this program began in 
2017, many other counties across the state joined the PDMP to have access to 
their resources. Governor Eric Greitens also decided the state needed to do more 
and signed the Executive Order directing the DHSS to implement a statewide 
PDMP. This program, as written, aims to punish prescribers and abusers. More 
importantly, the law already requires all prescribers and dispensers of controlled 
substances to record the information that the PDMP seeks, and that data is 
available to the BNDD upon request. The BNDD also already has the power, 
from the DHSS, to investigate and audit those who deal with controlled 
substances.  
This PDMP will likely prove to be an additional drain on resources (the 
contract with the pharmacy benefit organization and the purchase of technology 
to monitor the data), requiring additional funds to monitor information that is 
already being recorded. If Missouri chooses to continue with their statewide 
PDMP, the program should be integrated with the HIE that Missouri already has 
in place. Like Nebraska, this would allow physicians to get access to prescription 
history (something not currently allowed under Missouri’s PDMP) and treat 
patients while consulting their EMR to look for any problematic drug 
combinations or overprescribing of opioids. In this way, Missouri will be taking 
a more holistic approach to combatting opioid-related deaths and overdoses 
while continuing to provide efficient, patient-centered care.  
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